LONDON, May 26 (Reuters) - Vectura Group, a British
pharmaceutical company focused on inhaled medicines, said on
Wednesday it had agreed a 958 million pound ($1.36 billion)
takeover by global investment firm The Carlyle Group.
($1 = 0.7067 pounds)
(Reporting by Paul Sandle; Editing by Kate Holton)
![Alliance News](https://static.lse.co.uk/images/news-logos/alliance-news-logo.png)
Vectura Discontinues VR375 As Phase Three Study Misses Endpoints
LONDON (Alliance News) - Respiratory disease-focused pharmaceutical firm Vectura Group PLC said on Monday its phase three study of VR375 in adult and adolescent patients with severe uncontrolled a
Read more